Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations (SOR/2022-18)
Full Document:
- HTMLFull Document: Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations (Accessibility Buttons available) |
- XMLFull Document: Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations [121 KB] |
- PDFFull Document: Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations [362 KB]
Regulations are current to 2026-09-30 and last amended on 2022-02-27. Previous Versions
Marginal note:Registration
Footnote *57 (1) Subject to subsection (2), these Regulations come into force on the day on which they are registered.
Marginal note:Cessation of effect of interim order
(2) Sections 1 to 53 come into force on the day following the day on which the Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19, made by the Minister on May 3, 2021, and published in the Part I of the Canada Gazette on May 22, 2021, ceases to have effect.
Return to footnote *[Note: Sections 1 to 53 in force February 27, 2022.]
Page Details
- Date modified: